Insiders Nanobiotix

Equities

NANO

FR0011341205

Market Closed - Euronext Paris Other stock markets 11:35:17 2024-05-15 am EDT			5-day change	1st Jan Change
6.785 ^EUR	+0.37%		+9.79%	+2.18%

May. 14	Nanobiotix to Proceed to Phase 2 Trial of Lung Cancer Treatment	MT
Apr. 25	Transcript : Nanobiotix S.A., Q4 2023 Earnings Call, Apr 25, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva Shareholders OK One-tier Governance Model; New Chair Appointed	Dec. 21	MT
Nanobiotix appoints Chief Medical Officer	23-09-06	CF
Nanobiotix Appoints Chief Medical Officer	23-09-06	MT
Nanobiotix Appoints Kayitalire as Chief Medical Officer	23-09-05	MT
Nanobiotix SA Appoints Louis Kayitalire, as Chief Medical Officer	23-09-05	CI
NANOBIOTIX Announces the Appointment of Global Medical Experts to Scientific Advisory Board	22-11-02	CI
NANOBIOTIX Co-Founder and CEO Laurent Levy Named to 2022 PharmaVoice 100 List of Most Inspiring People in Life Sciences	22-09-06	BU
Nanobiotix S.A. Announces the Appointment of Bart Van Rhijn as Member of the Executive Board to Support Global Expansion	21-06-01	CI
Nanobiotix S.A. Announces the Appointment of Bart Van Rhijn as Chief Financial Officer	21-06-01	CI
Nanobiotix Announces Board Changes	21-05-25	CI
Nanobiotix S.A. Announces Executive Changes	19-07-01	CI
Nanobiotix Appoints Edwina Baskin-Bey as New Chief Medical Officer to Replace Elsa Borghi	19-06-04	CI
NANOBIOTIX Appoints Alain Dostie as Chief Operating Officer	17-02-07	CI
Nanobiotix Appoints Mihail Obrocea as the Head of U.S. Clinical Development and No?l Kurdi as the Director of Investor Relations	16-10-03	CI
Nanobiotix SA Appoints Patrick Tricoli as Vice President Corporate Development	14-09-22	CI
NANOBIOTIX Announces Executive Changes	14-01-16	CI
NANOBIOTIX Announces Executive Appointments	13-09-23	CI
Nanobiotix SA Announces Board Changes	13-02-13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW